Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Gruell

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Intensive Care Medicine Experimental|February 12, 2026
Time-series clustering analysis reveals distinct patterns of cytomegalovirus viremia in critically ill adultsJan-Hendrik Naendrup, Oliver Martin Hilbers, Henning Gruell, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 5, 2024
Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administrationSree Kurup, Nieves Velez de Mendizabal, Stephan Becker, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2012
A mouse model for HIV-1 entryJohn Pietzsch, Henning Gruell, Stylianos Bournazos, et al.
Blood Research|March 28, 2025
Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024Louise M Cremer, Jannik Stemler, Rosanne Sprute, et al.
Cell Host & Microbe|August 3, 2022
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patternsHenning Gruell, Kanika Vanshylla, Michael Korenkov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2017
Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial InfectionsIsabelle Suárez, Clara Lehmann, Henning Gruell, et al.
Immunity|November 30, 2023
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variantsMichael Korenkov, Matthias Zehner, Hadas Cohen-Dvashi, et al.
Journal of Clinical Microbiology|July 2, 2021
Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious IndividualsMichael Korenkov, Nareshkumar Poopalasingam, Matthias Madler, et al.
The Lancet. Respiratory Medicine|October 23, 2021
Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workersPinkus Tober-Lau, Tatjana Schwarz, Kanika Vanshylla, et al.
Science Immunology|November 17, 2023
Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell poolTimm Weber, Sabrina Dähling, Svea Rose, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Intensive Care Medicine Experimental|February 12, 2026
Time-series clustering analysis reveals distinct patterns of cytomegalovirus viremia in critically ill adultsJan-Hendrik Naendrup, Oliver Martin Hilbers, Henning Gruell, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 5, 2024
Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administrationSree Kurup, Nieves Velez de Mendizabal, Stephan Becker, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2012
A mouse model for HIV-1 entryJohn Pietzsch, Henning Gruell, Stylianos Bournazos, et al.
Blood Research|March 28, 2025
Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024Louise M Cremer, Jannik Stemler, Rosanne Sprute, et al.
Cell Host & Microbe|August 3, 2022
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patternsHenning Gruell, Kanika Vanshylla, Michael Korenkov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2017
Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial InfectionsIsabelle Suárez, Clara Lehmann, Henning Gruell, et al.
Immunity|November 30, 2023
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variantsMichael Korenkov, Matthias Zehner, Hadas Cohen-Dvashi, et al.
Journal of Clinical Microbiology|July 2, 2021
Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious IndividualsMichael Korenkov, Nareshkumar Poopalasingam, Matthias Madler, et al.
The Lancet. Respiratory Medicine|October 23, 2021
Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workersPinkus Tober-Lau, Tatjana Schwarz, Kanika Vanshylla, et al.
Science Immunology|November 17, 2023
Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell poolTimm Weber, Sabrina Dähling, Svea Rose, et al.
Pageof 9